Intocare 100 Capsule contains Itraconazole 100 mg, a broad-spectrum triazole antifungal agent used for the treatment of various fungal infections. Itraconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting cell membrane integrity and leading to fungal cell death. This medication is indicated for the management of systemic and superficial mycoses, including aspergillosis, blastomycosis, histoplasmosis, onychomycosis, and dermatophytosis. Intocare 100 Capsule is administered orally and is well-absorbed, with bioavailability enhanced when taken with food. It is metabolized primarily by the liver enzyme CYP3A4, necessitating caution when co-administered with drugs metabolized by the same pathway due to potential drug interactions. Common adverse effects include gastrointestinal disturbances such as nausea, vomiting, and abdominal pain, as well as headache and dizziness. Liver function should be monitored during prolonged therapy to detect hepatotoxicity early. Intocare 100 Capsule is contraindicated in patients with known hypersensitivity to itraconazole or other azole antifungals and in those with severe hepatic impairment. It should be used with caution in patients with cardiac conditions, as it may cause negative inotropic effects. Proper dosing and duration of therapy should be determined by a healthcare professional based on the type and severity of infection.